Daxor Co. (NASDAQ:DXR – Get Free Report) was down 4.6% on Wednesday . The company traded as low as $8.49 and last traded at $8.49. Approximately 355 shares were traded during trading, a decline of 87% from the average daily volume of 2,715 shares. The stock had previously closed at $8.90.
Daxor Stock Down 1.1 %
The company has a fifty day simple moving average of $8.94 and a 200-day simple moving average of $8.93.
Daxor Company Profile
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.
Recommended Stories
- Five stocks we like better than Daxor
- What Are Dividends? Buy the Best Dividend Stocks
- The Cannabis Sector: Profitability Takes Center Stage
- When to Sell a Stock for Profit or Loss
- Amazon’s Stock Plunge: Is a Prime Buying Opportunity Knocking?
- Investing in the High PE Growth Stocks
- Buy the Dip in e.l.f. Beauty: Analysts Point to a New High
Receive News & Ratings for Daxor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daxor and related companies with MarketBeat.com's FREE daily email newsletter.
